Early planned removal of umbilical venous catheters to prevent infection in newborn infants by Gordon, Adrienne et al.
This is a repository copy of Early planned removal of umbilical venous catheters to prevent
infection in newborn infants.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/122809/
Version: Published Version
Article:
Gordon, Adrienne, Greenhalgh, Mark and McGuire, William 
orcid.org/0000-0001-8572-3467 (2017) Early planned removal of umbilical venous 
catheters to prevent infection in newborn infants. Cochrane Database of Systematic 
Reviews. CD012142. ISSN 1469-493X 
https://doi.org/10.1002/14651858.CD012142.pub2
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Cochrane Database of Systematic Reviews
Early planned removal of umbilical venous catheters to
prevent infection in newborn infants (Review)
Gordon A, Greenhalgh M, McGuire W
Gordon A, Greenhalgh M, McGuire W.
Early planned removal of umbilical venous catheters to prevent infection in newborn infants.
Cochrane Database of Systematic Reviews 2017, Issue 10. Art. No.: CD012142.
DOI: 10.1002/14651858.CD012142.pub2.
www.cochranelibrary.com
Early planned removal of umbilical venous catheters to prevent infection in newborn infants (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . . . . . . . . . . . . . . . . . . .
4BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Figure 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Figure 4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Figure 5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Figure 6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Figure 7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
13DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
14AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
14ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
14REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
17CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
20DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 Early planned UVC removal vs later planned removal or expectant management, Outcome 1
Bloodstream infection. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Analysis 1.2. Comparison 1 Early planned UVC removal vs later planned removal or expectant management, Outcome 2
Bloodstream infection by micro-organism. . . . . . . . . . . . . . . . . . . . . . . . . 21
Analysis 1.3. Comparison 1 Early planned UVC removal vs later planned removal or expectant management, Outcome 3
All-cause mortality. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Analysis 1.4. Comparison 1 Early planned UVC removal vs later planned removal or expectant management, Outcome 4
Pericardial effusion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Analysis 1.5. Comparison 1 Early planned UVC removal vs later planned removal or expectant management, Outcome 5
Catheter-associated thrombosis necessitating removal of catheter. . . . . . . . . . . . . . . . . 23
Analysis 1.6. Comparison 1 Early planned UVC removal vs later planned removal or expectant management, Outcome 6
Number of cannulas or catheters used per infant. . . . . . . . . . . . . . . . . . . . . . . 24
Analysis 1.7. Comparison 1 Early planned UVC removal vs later planned removal or expectant management, Outcome 7
Necrotising enterocolitis (Bell stage 2 or 3). . . . . . . . . . . . . . . . . . . . . . . . 24
25APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
29CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
30DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
30SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
30DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
iEarly planned removal of umbilical venous catheters to prevent infection in newborn infants (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Early planned removal of umbilical venous catheters to
prevent infection in newborn infants
Adrienne Gordon1, Mark Greenhalgh2, William McGuire3
1Neonatology, Royal Prince Alfred Hospital, Sydney, Australia. 2RPA Newborn Care, RPA Women and Babies, Royal Prince Alfred
Hospital, Sydney, Australia. 3Centre for Reviews and Dissemination, The University of York, York, UK
Contact address: William McGuire, Centre for Reviews and Dissemination, The University of York, York, Y010 5DD, UK.
William.McGuire@hyms.ac.uk.
Editorial group: Cochrane Neonatal Group.
Publication status and date: New, published in Issue 10, 2017.
Citation: Gordon A, GreenhalghM,McGuire W. Early planned removal of umbilical venous catheters to prevent infection in newborn
infants. Cochrane Database of Systematic Reviews 2017, Issue 10. Art. No.: CD012142. DOI: 10.1002/14651858.CD012142.pub2.
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Lengthy duration of use may be a risk factor for umbilical venous catheter-associated bloodstream infection in newborn infants. Early
planned removal of umbilical venous catheters (UVCs) is recommended to reduce the incidence of infection and associated morbidity
and mortality.
Objectives
To compare the effectiveness of early planned removal of UVCs (up to two weeks after insertion) versus an expectant approach or a
longer ﬁxed duration in preventing bloodstream infection and other complications in newborn infants.
To perform subgroup analyses by gestational age at birth and prespeciﬁed planned duration of UVC placement (see “Subgroup analysis
and investigation of heterogeneity”).
Search methods
We used the standard Cochrane Neonatal search strategy including electronic searches of the Cochrane Central Register of Controlled
Trials (CENTRAL; 2017, Issue 4), Ovid MEDLINE, Embase, and the Maternity & Infant Care Database (until May 2017), as well
as conference proceedings and previous reviews.
Selection criteria
Randomised and quasi-randomised controlled trials that compared effects of early planned removal of UVCs (up to two weeks after
insertion) versus an expectant approach or a longer ﬁxed duration in preventing bloodstream infection and other complications in
newborn infants.
Data collection and analysis
Two review authors assessed trial eligibility and risk of bias and independently undertook data extraction. We analysed treatment effects
and reported risk ratio (RR) and risk difference (RD) for dichotomous data, and mean difference (MD) for continuous data, with
respective 95% conﬁdence intervals (CIs). We planned to use a ﬁxed-effect model in meta-analyses and to explore potential causes of
heterogeneity in sensitivity analyses. We assessed the quality of evidence for the main comparison at the outcome level using GRADE
methods.
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Main results
We found one eligible trial. Participants were 210 newborn infants with birth weight less than 1251 grams. The trial was unblinded but
otherwise of good methodological quality. This trial compared removal of an umbilical venous catheter within 10 days after insertion
(and replacement with a peripheral cannula or a percutaneously inserted central catheter as required) versus expectant management
(UVC in place up to 28 days). More infants in the early planned removal group than in the expectant management group (83 vs 33)
required percutaneous insertion of a central catheter (PICC). Trial results showed no difference in the incidence of catheter-related
bloodstream infection (RR 0.65, 95% CI 0.35 to 1.22), in hospital mortality (RR 1.12, 95% CI 0.42 to 2.98), in catheter-associated
thrombus necessitating removal (RR 0.33, 95% conﬁdence interval 0.01 to 7.94), or in other morbidity. GRADE assessment indicated
that the quality of evidence was “low” at outcome level principally as the result of imprecision and risk of surveillance bias due to lack
of blinding in the included trial.
Authors’ conclusions
Currently available trial data are insufﬁcient to show whether early planned removal of umbilical venous catheters reduces risk of
infection, mortality, or other morbidity in newborn infants. A large, simple, and pragmatic randomised controlled trial is needed to
resolve this ongoing uncertainty.
P L A I N L A N G U A G E S U M M A R Y
Early planned removal of umbilical venous catheters to prevent infection in newborn infants
Review question
In newborn infants with an umbilical venous catheter, how does planned removal within two weeks after insertion compare with an
expectant approach or a longer ﬁxed duration in preventing bloodstream infection and other complications?
Background
Preterm and sick term newborn babies may require an umbilical venous catheter (UVC) - a ﬁne plastic tube that is inserted via the
infant’s umbilical vein (in the tummy button) several centimetres into the infant’s major blood vessel to deliver nutrition and drugs.
Infection in the bloodstream is a frequent and harmful complication for newborn infants who have a UVC in place. One method that
may be used to reduce the risk of this and other serious complications is removal of the UVC within about two weeks after insertion
(rather than leaving it until no longer required) and replacement with a cannula or a catheter inserted via a small vein (usually in the
arm or leg).
Study characteristics
We found only one small randomised controlled trial (including 210 very low birth weight newborn infants) that addressed this
question.
Key results
This trial did not show that early planned removal of UVCs from infants could reduce their chance of developing a bloodstream
infection. However, because the trial was small, this ﬁnding is not certain.
Conclusions
The trial did not provide sufﬁcient evidence to inform policy or practice; larger trials are needed to resolve this question fully.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Early planned removal of umbilical venous catheters to prevent infect ion in newborn infants
Patients or population: newborn infants
Setting: healthcare sett ing
Intervention: early planned removal of UVC
Comparison: expectant management
Outcomes Illustrative comparative risks (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Downgraded for:
Risk with expectant
management
Risk with early planned
removal
Bloodstream infection
(during intervent ion pe-
riod)
202 per 1000 131 per 1000
(71 to 246)
RR 0.65 (0.35 to 1.22) 210 (1 trial) ⊕⊕©©
low
Imprecision
Design (risk of bias)
All- cause mortality
(up to hospital dis-
charge)
67 per 1000 75 per 1000
(28 to 201)
RR 1.12 (0.42 to 2.98) 210 (1 trial) ⊕⊕©©
low
Imprecision
Design (risk of bias)
Catheter-asso-
ciated thrombosis ne-
cessitating removal of
catheter
(during intervent ion pe-
riod)
10 per 1000 3 per 1000
(0 to 76)
RR 0.33 (0.01 to 7.94) 210 (1 trial) ⊕⊕©©
low
Imprecision
Design (risk of bias)
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
CI: conf idence interval.
RR: risk rat io.3
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B A C K G R O U N D
Description of the condition
Umbilical venous catheters (UVCs) are used to establish a secure
central vascular route for delivery of drugs or ﬂuids to preterm or
sick newborn infants. UVCs are usually inserted within the ﬁrst
few days after birth, when the umbilical cord stump can be manip-
ulated and the opening of the umbilical vein is patent and easily
visualised (Seguin 1994; Green 1998; Nash 2006). Evidence sug-
gests that use of UVCs rather than short peripheral venous cannu-
las facilitates consistent delivery of parenteral nutrients to preterm
infants and reduces the number of venipunctures that infants must
undergo (Pereira 1992). Because UVCs terminate within large
central vessels rather than small, fragile peripheral vessels, their use
may reduce the risk of subcutaneous extravasation injury caused
by hyperosmolar solutions and medications (Hermansen 2005).
As with other types of central vascular catheters (CVCs), use of
UVCs is associated with complications that may cause morbid-
ity and mortality (Wu 2012). Bloodstream infection is the most
common serious adverse event, with reported incidence ranging
from 3% to more than 20%, depending on the precise diagnostic
criteria applied and the demographics of the population studied
(O’Grady 2011; Schulman2011; Butler-O’Hara 2012).Newborn
infants, particularly very preterm infants, with acquired blood-
stream infection are at higher risk for mortality and for a range
of important morbidities including bronchopulmonary dyspla-
sia, necrotising enterocolitis, retinopathy of prematurity, and pro-
longed hospitalisation (Saint 2000; Chapman 2003; Payne 2004;
Adams-Chapman 2006; Hermans 2007; Lahra 2009). Blood-
stream infection is associated with higher rates of adverse neurode-
velopmental outcomes including cognitive or sensory impairment
and cerebral palsy (Stoll 2004; Shah 2008; Bassler 2009). Other
potentially serious complications of UVC use include thrombosis
formation in the catheter lumen or tip and thromboembolism,
arrhythmias triggered by a UVC tip positioned within the cardiac
chambers, and malposition or migration of the UVC tip within
peritoneal, pleural. or pericardial spaces (which can cause ascites,
pleural effusion, or cardiac tamponade), or within the portal ve-
nous system (which may result in hepatic necrosis and long-term
liver dysfunction) (Panetta 2000;Kim2001;Traen 2005; Shareena
2008; Narang 2009; Arnts 2014; Grizelj 2014; Hollingsworth
2015; Mutlu 2016).
Description of the intervention
Uncertainty surrounds the effects of duration of placement (’dwell
time’) on risk ofUVC-associated bloodstream infections and other
complications in newborn infants. Observational studies estimate
that risk of infection increases with dwell times longer than about
7 to 14 days (Seguin 1994; Zingg 2011; Butler-O’Hara 2012). It
is not certain, however, to what extent UVC use is an indepen-
dent risk factor for a bloodstream infection, or whether observed
associations exist because infants who are smaller, less mature, and
sicker who are receiving more intensive and invasive support are
more likely to have a UVC in place longer (Shahid 2014).
The US Centers for Disease Control and Prevention (CDC) Hos-
pital Infection Control Practices Advisory Committee currently
recommends that UVCs should be removed as soon as possible
when no longer needed but can be used for up to 14 days if man-
aged aseptically (O’Grady 2011). Consistent with these recom-
mendations, standard clinical practice in many neonatal units is
to remove UVCs before 14 days (often by 7 days). Replacement
intravenous access, if required, can be attained via short peripheral
cannulas, or via percutaneously inserted central catheters (PICCs)
if ongoing central access is needed (Wu 2012; Taylor 2014). It
is unclear, however, whether or how this strategy of serial central
line use affects rates of bloodstream infection and other catheter-
related complications (Keir 2014).
How the intervention might work
Prespecifying a ﬁxed maximum dwell time with planned removal
rather than an expectant approachmay reduce the risk that a UVC
may be left in place when not in use or needed. This could lower
the risk of bloodstream infection and its associated complications
if the UVC is an independent risk factor for bloodstream infec-
tion. This intervention may plausibly affect nutrient intake, re-
ducing receipt of parenteral nutrients or prompting a more rapid
progression to full enteral feeding, or both, with potential conse-
quences for acute morbidity (principally risk of acute necrotising
enterocolitis), growth, and development.
Why it is important to do this review
Given the fact that for the planned duration of UVC, placement
may affect important outcomes for newborn infants, we undertook
a systematic review to identify, appraise, and synthesise available
evidence from randomised controlled trials.
Related Cochrane Reviews
Other Cochrane Reviews have assessed effects of strategies includ-
ing antimicrobial impregnation or antibiotic locks in preventing
UVC- and other CVC-related infection in newborn infants, and
early removal versus expectant management of PICC in infants
with suspected bloodstream infection (Balain 2015; Taylor 2015).
Another review evaluated evidence for use of short-term versus
longer-term PICC in newborn infants (Gordon 2016).
O B J E C T I V E S
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To compare the effectiveness of early planned removal of umbilical
venous catheters (UVCs) (up to two weeks after insertion) versus
an expectant approach or a longer ﬁxed duration in preventing
bloodstream infection and other complications in newborn in-
fants.
To perform subgroup analyses by gestational age at birth and
prespeciﬁed planned duration of UVC placement (see Subgroup
analysis and investigation of heterogeneity).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised and quasi-randomised controlled trials, including
cluster-randomised controlled trials.
Types of participants
Newborn infants requiring a UVC for central vascular access.
Types of interventions
• Intervention: prespeciﬁed planned UVC removal at any day
up to 14 days after insertion
• Control: permissible duration of placement that is at least
seven days longer than speciﬁed for the intervention group, or a
permissive approach that does not prespecify dwell time but
allows for removal on clinical grounds (including suspected or
conﬁrmed bloodstream infection), or when the UVC is no
longer required
Trials that assessed the effects of a prespeciﬁed intendedduration of
UVC placement as part of a package of infection control measures
(care bundle) were eligible for inclusion, but we planned to analyse
these separately from trials of discrete interventions.
Types of outcome measures
Primary outcomes
• Incidence of bloodstream infection conﬁrmed by culture of
blood sampled from peripheral sites (not from indwelling
catheters) during hospital admission. When data were available,
we excluded cases in which infection was attributed to
diphtheroids, micrococci, Propionibacteriaceae, or mixed
microbial ﬂora. When sufﬁcient data were available, we
examined the effect on infection with:
◦ coagulase-negative staphylococci;
◦ other bacteria (Gram-negative bacilli, Staphylococcus
aureus, enterococci); or
◦ fungi.
Secondary outcomes
• Neonatal mortality (< 28 days) and death due to all causes
before hospital discharge and up to one year post term
• Neurodevelopmental outcomes assessed after 12 months
post term using validated tools: neurological evaluations;
developmental scores; and classiﬁcations of disability, including
auditory and visual disability. We deﬁned neurodevelopmental
impairment as the presence of one or more of the following:
non-ambulant cerebral palsy; developmental quotient more than
two standard deviations below the population mean; and
blindness (visual acuity < 6/60) or deafness (any hearing
impairment requiring or unimproved by ampliﬁcation)
• Death or neurological impairment assessed after 12 months
post term
• Growth: time (days) to regain birth weight and average
rates of weight gain (grams/kg/d), linear growth (mm/week),
head growth (mm/week) and skinfold thickness growth (mm/
week) during hospital admission
• Extravasation injury: subcutaneous extravasation resulting
in skin ulceration; ’deep’ extravasation resulting in limb swelling;
or ’central’ extravasation-infusate in the pleural, peritoneal, or
pericardial space
• Number of cannulas or catheters used per infant to
administer parenteral ﬂuids until full enteral feeding was
established
• Days to full enteral feeding
• Central catheter leak, obstruction, or breakage necessitating
removal of the catheter
• Catheter-associated thrombosis necessitating removal of the
catheter
• Other morbidity developing after enrolment in the trial
until discharge from the hospital
◦ Bronchopulmonary dysplasia (oxygen
supplementation at 36 weeks’ postmenstrual age) (Ehrenkranz
2005)
◦ Necrotising enterocolitis (Bell stage 2 or 3) (Walsh
1986)
◦ Retinopathy of prematurity requiring treatment
(medical or surgical) (ICROP 2005)
Search methods for identification of studies
See the Cochrane Neonatal Review Group search strategy (http:/
/neonatal.cochrane.org/).
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Electronic searches
We searched the Cochrane Central Register of Controlled Tri-
als (CENTRAL; 2017, issue 5), Ovid MEDLINE (1946 to May
2017), OVID Embase (1974 to May 2017), OVID Maternity &
Infant Care Database (1971 to May 2017), and the Cumulative
Index to Nursing and Allied Health Literature (CINAHL; 1982
to May 2017) using a combination of the text words and MeSH
terms presented in Appendix 1. We limited search outputs by us-
ing relevant search ﬁlters for clinical trials as recommended in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011). We did not apply language restrictions.
We searched ClinicalTrials.gov and the International Trials Reg-
istry Platform of the World Health Organization (www.whoint/
ictrp/search/en/) for completed and ongoing trials.
Searching other resources
We examined reference lists in previous reviews and included stud-
ies. We searched the proceedings of annual meetings of the Pe-
diatric Academic Societies (1993 to 2017), the European Society
for Pediatric Research (1995 to 2016), the Royal College of Pae-
diatrics and Child Health (2000 to 2017), and the Perinatal Soci-
ety of Australia and New Zealand (2000 to 2016). Trials reported
only as abstracts were eligible if sufﬁcient information was avail-
able from the report, or from contact with trial authors, to fulﬁl
the inclusion criteria.
Data collection and analysis
We used the standard methods of Cochrane Neonatal.
Selection of studies
We screened the title and abstract of all studies identiﬁed by the
above search strategy, and two review authors independently as-
sessed the full articles for all potentially relevant trials.We excluded
studies that do not meet all of the inclusion criteria. We discussed
disagreements until we achieved consensus.
Data extraction and management
Two review authors (MG and WM) extracted data independently
using a data collection form to collect from each included study
information on design, methods, participants, interventions, out-
comes, and treatment effects.We discussed disagreements until we
reached a consensus. If data from trial reports were insufﬁcient,
we contacted trialists to request further information.
Assessment of risk of bias in included studies
We used the criteria and standard methods of Cochrane Neonatal
to assess the methodological quality of included trials. Two review
authors assessed risk of bias across key domains and resolved dis-
agreements in consultation with a third review author (Appendix
2). We planned to request additional information from trial au-
thors to clarify methods and results when necessary. We did not
exclude trials on the basis of risk of bias, but we did plan to con-
duct sensitivity analyses if applicable to explore the consequences
of synthesising evidence of variable quality (Higgins 2011).
Measures of treatment effect
We analysed treatment effects in individual trials using RevMan
2014 and reported risk ratio (RR) and risk difference (RD) for di-
chotomous data, and mean difference (MD) for continuous data,
with respective 95% conﬁdence intervals (CIs). We determined
the number needed to treat for an additional beneﬁcial outcome
(NNTB) or an additional harmful outcome (NNTH) for analyses
with a statistically signiﬁcant difference in RD.
Unit of analysis issues
The unit of analysis was the participating infant in individually
randomised trials, and the neonatal unit (or sub-unit) in cluster-
randomised trials.
An infant was to be considered only once in an analysis. We
planned to exclude infants with multiple enrolments, as we would
not be able to address the unit of analysis issues that might arise.
For cluster-randomised trials, we planned to undertake analyses at
the level of the individual while accounting for clustering of data
using the methods recommended in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011).
Dealing with missing data
When data were missing and could not be derived as described,
we planned to approach the analysis as follows.
• Contact original study investigators to request missing data.
• When possible, impute missing standard deviations (SDs)
using the coefﬁcient of variation (CV), or calculate from other
available statistics including standard errors, conﬁdence intervals,
t values, and P values.
• If data were assumed to be missing at random, analyse the
data without imputing missing values.
• If this could not be assumed, impute missing outcomes
with replacement values, assuming all to have a poor outcome.
We planned to conduct sensitivity analyses to assess changes in the
direction or magnitude of effect resulting from data imputation.
Assessment of heterogeneity
Two review authors (WM andMG) planned to assess clinical het-
erogeneity, and undertook a meta-analysis only when both review
authors agreed that study participants, interventions, and out-
comeswere sufﬁciently similar.We planned to assess statistical het-
erogeneity through visual inspection of forest plots. We planned
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to calculate the I² statistic for each RR analysis to quantify incon-
sistency across studies and to describe the percentage of variability
in effect estimates that may be due to heterogeneity rather than
to sampling error. If we detected ’high’ levels of heterogeneity (I²
≥ 75%), we planned to explore possible causes (e.g. differences
in study design, participants, interventions, completeness of out-
come assessments).
Assessment of reporting biases
We planned to assess publication bias through visual inspection of
funnel plot asymmetry in meta-analyses consisting of at least 10
trials.
Data synthesis
We planned to use the ﬁxed-effect model in Review Manager 5.3
for meta-analyses (as per Cochrane Neonatal recommendations).
Quality of evidence
We assessed the quality of evidence for main comparisons at the
primary outcomes level using theGRADEapproach, as outlined in
the GRADE Handbook (Guyatt 2011a; Schünemann 2013). Two
review authors independently assessed the quality of the evidence
for outcomes identiﬁed as critical or important for clinical decision
making (i.e. infection, death, and thrombosis). We considered
evidence from randomised controlled trials as high quality but
downgraded the evidence one level for serious (or two levels for
very serious) limitations based upon the following: design (risk of
bias), consistency across studies, directness of evidence, precision
of estimates, and presence of publication bias (Appendix 3). We
used GRADEproGDT to create a ‘Summary of ﬁndings’ table to
report the quality of the evidence (GRADEproGDT).
Subgroup analysis and investigation of heterogeneity
If we identify sufﬁcient studies, we planned to undertake these
subgroup analyses.
• Very preterm (< 32 weeks) infants (vs infants born at ≥ 32
weeks).
• Prespeciﬁed planned duration of UVC placement up to 7
days (vs longer durations up to 14 days).
Sensitivity analysis
Weplanned to undertake sensitivity analyses to determine whether
ﬁndings were affected by including only studies using adequate
methods (low risk of bias), deﬁned as adequate randomisation and
allocation concealment, blinding of intervention, and measure-
ment, with < 10% loss to follow-up.
R E S U L T S
Description of studies
Results of the search
We included one trial and excluded seven reports (Figure 1.
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Figure 1. Study flow diagram.
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Included studies
We included one trial, which was conducted between 1998 and
2004 at a tertiary referral neonatal unit in theUSA (Butler O’Hara
2006; Characteristics of included studies). Infants of birth weight
less than 1251 grams who had a double-lumen UVC placed upon
admission to the neonatal unit were eligible for participation in the
study. Trialists excluded infants who required a UVC for exchange
transfusion, infants with gastrointestinal abnormalities, and in-
fants with congenital heart disease.
For infants in the intervention (early planned removal) arm (N
= 106), the UVC remained in place for up to 7 to 10 days. If
ongoing central access was required, a PICC was placed by day
10, at which time the UVC was removed. If a PICC was removed
for any reason and further central access was required, another
PICC was placed. In the control (expectant management) group
(N = 104), when the UVC was no longer needed, or by 28 days
at the latest, the UVC was removed. Before 28 days if the UVC
was removed for any reason and central access was still required, a
further UVC was placed. At 28 days, if the infant was not close to
full enteral feeds and required central venous access, a PICC was
placed at the discretion of the team.
For both groups, the clinical team decided on the overall duration
of central venous access, with CVCs removed when the infant no
longer required parenteral nutrition, approached full enteral feeds,
or had peripheral vascular access.More infants in the early planned
removal group than in the expectant management group required
percutaneous insertion of a central catheter (83 vs 33). The report
does not specify which other infection control precautions (e.g.
practices to scrub the hub before line entry) were taken during
the trial, or whether these were standardised for both intervention
and control groups.
We assessed all outcomes in an intention-to-treat manner. The pri-
mary outcome was time to catheter-related bloodstream infection
and incidence of catheter-related infection (deﬁned as symptoms,
positive blood culture, CVC in place). We counted each infant
only once as having catheter-related infection during the study
regardless of future blood culture results. This did not include
late-onset bloodstream infections that occurred after removal of
the CVC. Secondary outcomes included CVC-related thrombo-
sis, haemorrhage, arrhythmia, pericardial effusion, or pleural effu-
sion. We planned to perform secondary outcome assessment for
portal hypertension at age ﬁve years, but no data have yet been
published.
Excluded studies
We excluded seven studies (Khilnani 1991; Landers 1991; Davey
1994; Loisel 1996; Boo 1999; Gharehbaghi 2011; Keir 2014;
Characteristics of excluded studies).
Risk of bias in included studies
We included only one trial (Butler O’Hara 2006).
Allocation
Investigators assigned participating infants to intervention or con-
trol using a block randomisation scheme derived from a random
numbers table. Allocation took place via opaque randomisation
envelopes.
Blinding
The study group was not blinded to parents, caregivers, or man-
aging clinical staff. It is unclear whether outcome assessment was
blinded.
Incomplete outcome data
Study authors reported all participant data for primary outcomes.
Some data for secondary outcomes were missing - some were pro-
vided by study authors - as were some one-year follow-up re-
views (with participants presumably lost to follow-up, although
not stated).
Other potential sources of bias
We detected potential ascertainment bias. We noted difﬁculty in
obtaining paired blood cultures (from peripheral and catheter) for
four of the eight bloodstream infection events in the short-term
group in which a non-deﬁnitive pathogen (all coagulase-negative
staphylococci) was isolated. This may have improved detection of
bloodstream infection over the long term in the UVC group, for
which paired conﬁrmatory samples were easier to take from the
UVC.
Effects of interventions
See: Summary of ﬁndings for the main comparison
Primary outcomes
• Conﬁrmed bloodstream infection (Analysis 1.1): Trialists
reported this as the number of infants with a microbiologically
conﬁrmed bloodstream infection during the trial period (28
days) when a catheter was in place. Trial data did not show a
difference (RR 0.65, 95% CI 0.35 to 1.22; RD -0.07, 95% CI
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-0.17 to 0.03; Figure 2). Results described 7.4 infections per
1000 catheter-days in the short-term group, and 11.5 per 1000
in the long-term group
Figure 2. Forest plot of comparison: 1 Early planned UVC removal vs later planned removal or expectant
management, outcome: 1.1 Bloodstream infection.
• Conﬁrmed bloodstream infection by type of micro-
organism (Analysis 1.2). Data showed no effect on infections
with:
◦ coagulase-negative staphylococci: RR 0.49, 95% CI
0.19 to 1.26; RD -0.06, 95% CI -0.13 to 0.02;
◦ other bacteria: RR 0.61, 95% CI 0.21 to 1.81; RD
-0.03, 95% CI -0.09 to 0.04; or
◦ fungi: RR 1.96, 95% CI 0.18 to 21.31; RD 0.01,
95% CI -0.02 to 0.04.
Secondary outcomes
• Mortality
◦ Neonatal mortality: not reported
◦ Death before hospital discharge (Analysis 1.3): Data
showed no difference (RR 1.12, 95% CI 0.42 to 2.98; RD 0.01,
95% CI -0.06 to 0.08; Figure 3)
Figure 3. Forest plot of comparison: 1 Early planned UVC removal vs later planned removal or expectant
management, outcome: 1.3 All-cause mortality.
◦ Death up to one year post term due to all causes: not
reported
• Neurodevelopmental outcomes: not reported
• Death or neurological impairment: not reported
• Growth
◦ Days to regain birth weight: Trial data did not show a
statistically signiﬁcant difference (median 9 (range 0 to 27) vs 10
(0 to 33))
◦ Average rates of weight gain, linear growth, head
growth, and skinfold thickness growth during hospital
admission: not reported
• Extravasation injury (Analysis 1.4)
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◦ Subcutaneous extravasation resulting in skin
ulceration; ’deep’ extravasation resulting in limb swelling: not
reported
◦ ’Central’ extravasation - infusate in the pleural,
peritoneal, or pericardial space: Data showed no difference in the
incidence of pericardial effusion (RR 0.98, 95% CI 0.33 to 2.94;
RD -0.0, 95% CI -0.06 to 0.06; Figure 4). None of the infants
developed a pleural or peritoneal effusion
Figure 4. Forest plot of comparison: 1 Early planned UVC removal vs later planned removal or expectant
management, outcome: 1.4 Pericardial effusion.
• Catheter-associated thrombosis necessitating removal of
catheter (Analysis 1.5). Trial data did not show a difference (RR
0.33, 95% CI 0.01 to 7.94; RD -0.01, 95% CI -0.04 to 0.02;
Figure 5)
Figure 5. Forest plot of comparison: 1 Early planned UVC removal vs later planned removal or expectant
management, outcome: 1.5 Catheter-associated thrombosis necessitating removal of catheter.
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• Number of cannulas or catheters used per infant to
administer parenteral ﬂuids until full enteral feeding established
(Analysis 1.6): Trial data show the number of catheters (UVC or
PICC) placed until day 28. The early planned removal group
received more catheters on average: MD 0.24 (95% CI 0.05 to
0.43) (Figure 6)
Figure 6. Forest plot of comparison: 1 Early planned UVC removal vs later planned removal or expectant
management, outcome: 1.6 Number of cannulas or catheters used per infant.
• Days to full enteral feeding: Trial results did not show a
difference (median 23 days (range 7 to 101) vs 22 days (range 7
to 136))
• Central catheter leak, obstruction, or breakage necessitating
removal of catheter: Data show this outcome per total number of
catheters, not per infant. In the intervention group, 27 of 210
CVCs were removed versus 27 of 181 in the expectant
management group
• Other morbidity developing until discharge from hospital
◦ Bronchopulmonary dysplasia: not reported
◦ Necrotising enterocolitis (Bell stage 2 or 3) (Analysis
1.7): Trial data did not show a difference (RR 0.62, 95% CI 0.25
to 1.55; RD -0.04, 95% CI -0.12 to 0.04; Figure 7)
Figure 7. Forest plot of comparison: 1 Early planned UVC removal vs later planned removal or expectant
management, outcome: 1.7 Necrotising enterocolitis (Bell stage 2 or 3).
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◦ Retinopathy of prematurity: not reported
Subgroup analyses
• Very preterm (< 32 weeks) infants (vs infants born at or later
than 32 weeks): A vast majority of participants are likely to have
been very preterm (average gestational age 27 weeks, SD 2 weeks)
• Prespeciﬁed planned duration of UVC placement: All
participants had planned UVC placement for 7 to 10 days
D I S C U S S I O N
Summary of main results
We found one trial for inclusion in this review (Butler O’Hara
2006). This trial was unblinded but otherwise of good method-
ological quality. Trial data did not show any effects of the interven-
tion on the incidence of catheter-related bloodstream infection,
or on hospital mortality, other catheter-related complications (in-
cluding thrombosis), or neonatal morbidity (including necrotis-
ing enterocolitis).
Overall completeness and applicability of
evidence
We identiﬁed one small trial (N = 210) for inclusion in this review
(Butler O’Hara 2006). Trial data did not provide evidence that
a policy of early planned removal of umbilical venous catheters
(UVCs) (with replacement by a peripheral cannula or a percuta-
neously inserted central catheter (PICC) if needed) affected the
risk of catheter-related bloodstream infection in newborn infants
of birth weight less than 1251 grams. The event rate in the control
group (20% incidence of bloodstream infection) is comparable
with that of other studies, and ﬁndings are likely to be generally
applicable to healthcare settings in high-income and middle-in-
come countries with similar populations and care practices (Arnts
2014; Shalabi 2015). The wide 95% conﬁdence interval (CI) for
the risk ratio (RR) estimate (0.35 to 1.22), however, indicates that
a substantial and important effect on risk of bloodstream infection
cannot yet be excluded.
The included trial reported catheter-related bloodstream infection,
that is, laboratory culture of a pathogenic micro-organism from
blood (sampled from a peripheral site) “while a catheter was in
place”. This deﬁnition is similar to the US Centers for Disease
Control and Prevention (CDC) deﬁnition of central line-associ-
ated bloodstream infection that is used in surveillance studies, and
it is consistent with the plausible effect of the intervention in re-
ducing bloodstream infection risk by removing intravascular de-
vices that may act as a portal or reservoir for infecting organisms.
The primary ﬁnding that rates of bloodstream infection were not
statistically signiﬁcantly different between groups is possibly due
to the fact that infants in each group had a central venous catheter
(CVC) (either a UVC, or a UVC followed by a PICC) in place
for similar total durations up to 28 days. Observational studies do
not show differences in the risk of bloodstream infection among
infants with a UVC versus a PICC in place (Arnts 2014; Shalabi
2015). More infants in the early planned removal group than in
the expectant management group, however, required insertion of
a PICC (83 vs 33), and infants in the early planned removal group
required placement of, on average, 0.24moreCVCsduring the 28-
day trial period. The importance of these differences for infants,
families, caregivers, and services (including the impact on cost-
effectiveness) is uncertain.
Similarly, available data are insufﬁcient to permit exclusionof plau-
sible and important effects on secondary outcomes. For example,
the wide 95% CI bounds for the estimate of effect on mortality
before hospital discharge include risk reduced by more than half
and risk increasedmore than three-fold. This trial has not reported
long-term (post-hospital discharge) data.
The included trial recruited only infants of birth weight less than
1251 grams, and whilst this group makes up a large proportion
of infants who receive UVCs in neonatal units, a large number of
heavier babies also require this form of central venous access. The
incidence of, and risks for, CVC-associated infection vary between
very low birth weight and heavier infants, and data from this trial
may not be directly applicable to, for example, term or near-term
infants.
Quality of the evidence
Although allocation was concealed, the trial intervention was not
blinded to caregivers and investigators, and surveillance bias may
have inﬂuenced assessment of some outcomes, including blood-
stream infection. Clinicians’ subjective assessment of when to in-
vestigate for infection may have been affected by the perception
that longer dwell times increased the risk of catheter-related infec-
tion. The unblinded design may have inﬂuenced other care prac-
tices. For example, the perception that longer-term UVC place-
ment might increase the risk of infection may inﬂuence adherence
of healthcare staff to other infection control practices.
These trial design concerns, together with imprecision of estimates
of effect, mean that the overall quality of evidence for key out-
comes (i.e. bloodstream infection, mortality, catheter-associated
thrombosis) is “low” according toGRADEWorking Group grades
of evidence (Summary of ﬁndings for the main comparison). Fur-
ther research is very likely to have an important impact on our
conﬁdence in current estimates of effect and is likely to change the
estimates.
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Potential biases in the review process
We found only one trial for inclusion in this review. Although we
conducted a comprehensive search, including a search of confer-
ence proceedings, we cannot exclude fully the possibility of publi-
cation bias because we do not know whether other published (but
not indexed) or unpublished trials have been conducted.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We found a paucity of trial data to support or refute the hypothesis
that early planned removal of umbilical venous catheters (UVCs)
affects risk of infection among newborn infants. The only trial
conducted to address this question does not provide sufﬁcient
evidence to guide policy or clinical practice.
Implications for research
Given the potential for beneﬁt and harm to be associated with
timing of removal of the UVC from a neonate, a pragmatic ran-
domised controlled trial of early planned removal versus expectant
management may be warranted. Such a trial might include infants
at elevated risk of catheter-related bloodstream infection because
of an anticipated need for a prolonged period of central vascular
access for delivery of parenteral nutrition (e.g. extremely preterm
infants, growth-compromised infants) and might address primar-
ily the effect of early planned removal (e.g. by 7 to 14 days) on risk
of catheter-related bloodstream infection (deﬁned by established
and validated criteria). A large, simple, pragmatic trial would be
needed to allow assessment of a modest but important reduction
in the incidence of bloodstream infection (e.g. > 2000 participants
to provide 90% power to detect 25% risk ratio (RR) reduction),
as well as effects on other catheter- and infection-related compli-
cations.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Butler O’Hara 2006
Methods Randomised controlled trial
Participants Infants with birth weight < 1251 grams and a UVC in situ (N = 210)
Interventions Short-term (< 10 days) UVC use followed by PICC line placement vs expectant man-
agement (UVC in place up to 28 days)
Outcomes Incidence of microbiologically conﬁrmed CVC-related bloodstream infection (CVC in
place)
Catheter-associated thrombus (detected by ultrasound surveillance), haemorrhage, ar-
rhythmia, pericardial effusion, or pleural effusion
Days to full feeds and rate of weight gain, and incidence of feeding intolerance and
necrotising enterocolitis
Notes Study authors provided unpublished data on days to full feeding and days to regain birth
weight
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table. Block randomisation in groups
of 10 for 2 strata
Allocation concealment (selection bias) Low risk Opaque sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study group assignments were not masked
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It is not stated who measured outcomes, and whether
those who performed measurements were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Primary outcomes: All participants were accounted for
CVC: central venous catheter.
PICC: peripherally inserted central catheter.
UVC: umbilical venous catheter.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Boo 1999 Not an RCT
Davey 1994 RCT of early vs delayed enteral feeding in infants with umbilical catheters in situ
Gharehbaghi 2011 Not an RCT
Keir 2014 Not an RCT
Khilnani 1991 RCT of single- vs double-lumen UVC (not duration of use)
Landers 1991 Not an RCT
Loisel 1996 RCT of single- vs double-lumen UVC use for up to 14 days (not an RCT on duration of use)
RCT: randomised controlled trial.
UVC: umbilical venous catheter.
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D A T A A N D A N A L Y S E S
Comparison 1. Early planned UVC removal vs later planned removal or expectant management
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Bloodstream infection 1 210 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.35, 1.22]
2 Bloodstream infection by
micro-organism
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 Coagulase-negative
staphylococcus
1 210 Risk Ratio (M-H, Fixed, 95% CI) 0.49 [0.19, 1.26]
2.2 Other bacteria 1 210 Risk Ratio (M-H, Fixed, 95% CI) 0.61 [0.21, 1.81]
2.3 Fungi 1 210 Risk Ratio (M-H, Fixed, 95% CI) 1.96 [0.18, 21.31]
3 All-cause mortality 1 210 Risk Ratio (M-H, Fixed, 95% CI) 1.12 [0.42, 2.98]
4 Pericardial effusion 1 210 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.33, 2.94]
5 Catheter-associated thrombosis
necessitating removal of
catheter
1 210 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 7.94]
6 Number of cannulas or catheters
used per infant
1 210 Mean Difference (IV, Fixed, 95% CI) 0.24 [0.05, 0.43]
7 Necrotising enterocolitis (Bell
stage 2 or 3)
1 210 Risk Ratio (M-H, Fixed, 95% CI) 0.62 [0.25, 1.55]
Analysis 1.1. Comparison 1 Early planned UVC removal vs later planned removal or expectant
management, Outcome 1 Bloodstream infection.
Review: Early planned removal of umbilical venous catheters to prevent infection in newborn infants
Comparison: 1 Early planned UVC removal vs later planned removal or expectant management
Outcome: 1 Bloodstream infection
Study or subgroup
Early
planned
removal
Expectant
manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Butler O’Hara 2006 14/106 21/104 100.0 % 0.65 [ 0.35, 1.22 ]
Total (95% CI) 106 104 100.0 % 0.65 [ 0.35, 1.22 ]
Total events: 14 (Early planned removal), 21 (Expectant management)
Heterogeneity: not applicable
Test for overall effect: Z = 1.34 (P = 0.18)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours early removal Favours expectant mgt
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Analysis 1.2. Comparison 1 Early planned UVC removal vs later planned removal or expectant
management, Outcome 2 Bloodstream infection by micro-organism.
Review: Early planned removal of umbilical venous catheters to prevent infection in newborn infants
Comparison: 1 Early planned UVC removal vs later planned removal or expectant management
Outcome: 2 Bloodstream infection by micro-organism
Study or subgroup
Early
planned
removal Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Coagulase-negative staphylococcus
Butler O’Hara 2006 6/106 12/104 100.0 % 0.49 [ 0.19, 1.26 ]
Subtotal (95% CI) 106 104 100.0 % 0.49 [ 0.19, 1.26 ]
Total events: 6 (Early planned removal), 12 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.48 (P = 0.14)
2 Other bacteria
Butler O’Hara 2006 5/106 8/104 100.0 % 0.61 [ 0.21, 1.81 ]
Subtotal (95% CI) 106 104 100.0 % 0.61 [ 0.21, 1.81 ]
Total events: 5 (Early planned removal), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.88 (P = 0.38)
3 Fungi
Butler O’Hara 2006 2/106 1/104 100.0 % 1.96 [ 0.18, 21.31 ]
Subtotal (95% CI) 106 104 100.0 % 1.96 [ 0.18, 21.31 ]
Total events: 2 (Early planned removal), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.58)
Test for subgroup differences: Chi2 = 1.13, df = 2 (P = 0.57), I2 =0.0%
0.05 0.2 1 5 20
......................... .........................
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Analysis 1.3. Comparison 1 Early planned UVC removal vs later planned removal or expectant
management, Outcome 3 All-cause mortality.
Review: Early planned removal of umbilical venous catheters to prevent infection in newborn infants
Comparison: 1 Early planned UVC removal vs later planned removal or expectant management
Outcome: 3 All-cause mortality
Study or subgroup
Early
planned
removal
Expectant
manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Butler O’Hara 2006 8/106 7/104 100.0 % 1.12 [ 0.42, 2.98 ]
Total (95% CI) 106 104 100.0 % 1.12 [ 0.42, 2.98 ]
Total events: 8 (Early planned removal), 7 (Expectant management)
Heterogeneity: not applicable
Test for overall effect: Z = 0.23 (P = 0.82)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours early removal Favours expectant mgt
Analysis 1.4. Comparison 1 Early planned UVC removal vs later planned removal or expectant
management, Outcome 4 Pericardial effusion.
Review: Early planned removal of umbilical venous catheters to prevent infection in newborn infants
Comparison: 1 Early planned UVC removal vs later planned removal or expectant management
Outcome: 4 Pericardial effusion
Study or subgroup
Early
planned
removal
Expectant
manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Butler O’Hara 2006 6/106 6/104 100.0 % 0.98 [ 0.33, 2.94 ]
Total (95% CI) 106 104 100.0 % 0.98 [ 0.33, 2.94 ]
Total events: 6 (Early planned removal), 6 (Expectant management)
Heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.97)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours early removal Favours expectant mgt
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Analysis 1.5. Comparison 1 Early planned UVC removal vs later planned removal or expectant
management, Outcome 5 Catheter-associated thrombosis necessitating removal of catheter.
Review: Early planned removal of umbilical venous catheters to prevent infection in newborn infants
Comparison: 1 Early planned UVC removal vs later planned removal or expectant management
Outcome: 5 Catheter-associated thrombosis necessitating removal of catheter
Study or subgroup
Early
planned
removal
Expectant
manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Butler O’Hara 2006 0/106 1/104 100.0 % 0.33 [ 0.01, 7.94 ]
Total (95% CI) 106 104 100.0 % 0.33 [ 0.01, 7.94 ]
Total events: 0 (Early planned removal), 1 (Expectant management)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours early removal Favours expectant mgt
23Early planned removal of umbilical venous catheters to prevent infection in newborn infants (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.6. Comparison 1 Early planned UVC removal vs later planned removal or expectant
management, Outcome 6 Number of cannulas or catheters used per infant.
Review: Early planned removal of umbilical venous catheters to prevent infection in newborn infants
Comparison: 1 Early planned UVC removal vs later planned removal or expectant management
Outcome: 6 Number of cannulas or catheters used per infant
Study or subgroup
Early
planned
removal
Expectant
manage-
ment
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Butler O’Hara 2006 106 1.98 (0.63) 104 1.74 (0.75) 100.0 % 0.24 [ 0.05, 0.43 ]
Total (95% CI) 106 104 100.0 % 0.24 [ 0.05, 0.43 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.51 (P = 0.012)
Test for subgroup differences: Not applicable
-0.2 -0.1 0 0.1 0.2
Favours early removal Favours expectant mgt
Analysis 1.7. Comparison 1 Early planned UVC removal vs later planned removal or expectant
management, Outcome 7 Necrotising enterocolitis (Bell stage 2 or 3).
Review: Early planned removal of umbilical venous catheters to prevent infection in newborn infants
Comparison: 1 Early planned UVC removal vs later planned removal or expectant management
Outcome: 7 Necrotising enterocolitis (Bell stage 2 or 3)
Study or subgroup
Early
planned
removal
Expectant
manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Butler O’Hara 2006 7/106 11/104 100.0 % 0.62 [ 0.25, 1.55 ]
Total (95% CI) 106 104 100.0 % 0.62 [ 0.25, 1.55 ]
Total events: 7 (Early planned removal), 11 (Expectant management)
Heterogeneity: not applicable
Test for overall effect: Z = 1.02 (P = 0.31)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours early removal Favours expectant mgt
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A P P E N D I C E S
Appendix 1. Electronic searches
Database: Epub Ahead of Print, In-Process&Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R)
<1946 to Present>
Search date = 11 May 2017
--------------------------------------------------------------------------------
1 exp Infant, Newborn/ (561659)
2 Premature Birth/ (10046)
3 (neonat$ or neo nat$).ti,ab. (231996)
4 (newborn$ or new born$ or newly born$).ti,ab. (150691)
5 (preterm or preterms or pre term or pre terms).ti,ab. (61041)
6 (preemie$ or premie or premies).ti,ab. (142)
7 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (13998)
8 (low adj3 (birthweight$ or birth weight$)).ti,ab. (30648)
9 (lbw or vlbw or elbw).ti,ab. (7095)
10 infan$.ti,ab. (388884)
11 (baby or babies).ti,ab. (62184)
12 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 (954982)
13 exp Catheterization, Central Venous/ (13775)
14 catheters/ or catheters, indwelling/ or central venous catheters/ (22236)
15 (central adj3 line$).ti,ab. (4845)
16 peripherally-inserted.ti,ab. (1191)
17 CVC.ti,ab. (3421)
18 CVL.ti,ab. (723)
19 PCVC.ti,ab. (29)
20 PICC.ti,ab. (818)
21 Umbilical Veins/ (12484)
22 UVC.ti,ab. (1531)
23 UAC.ti,ab. (326)
24 (umbilical adj3 cathet$).ti,ab. (1353)
25 (umbilical adj3 cannul$).ti,ab. (68)
26 (umbilical adj3 line$).ti,ab. (303)
27 Broviac.ti,ab. (345)
28 Hickman.ti,ab. (868)
29 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 (53640)
30 12 and 29 (5826)
31 randomized controlled trial.pt. (462319)
32 controlled clinical trial.pt. (94052)
33 randomized.ab. (403854)
34 placebo.ab. (188944)
35 drug therapy.fs. (1992401)
36 randomly.ab. (280501)
37 trial.ab. (422891)
38 groups.ab. (1728008)
39 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 (4102646)
40 exp animals/ not humans.sh. (4397724)
41 39 not 40 (3547814)
42 30 and 41 (1083)
******************************************************
Database:Embase <1974 to 2017 May 10>
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Search date = 11 May 2017
--------------------------------------------------------------------------------
1 newborn/ (517554)
2 prematurity/ (86628)
3 (neonat$ or neo nat$).ti,ab. (287899)
4 (newborn$ or new born$ or newly born$).ti,ab. (177117)
5 (preterm or preterms or pre term or pre terms).ti,ab. (80444)
6 (preemie$ or premie or premies).ti,ab. (203)
7 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (17967)
8 (low adj3 (birthweight$ or birth weight$)).ti,ab. (36575)
9 (lbw or vlbw or elbw).ti,ab. (9138)
10 infan$.ti,ab. (439127)
11 (baby or babies).ti,ab. (81178)
12 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 (1036635)
13 exp central venous catheterization/ (8081)
14 catheter/ (49569)
15 exp indwelling catheter/ (12385)
16 exp central venous catheter/ or hickman catheter/ or peripherally inserted central venous catheter/ or subclavian vein catheter/
(18067)
17 (central adj3 line$).ti,ab. (7592)
18 peripherally-inserted.ti,ab. (1889)
19 CVC.ti,ab. (5399)
20 CVL.ti,ab. (1020)
21 PCVC.ti,ab. (45)
22 PICC.ti,ab. (1828)
23 umbilical vein/ (13825)
24 UVC.ti,ab. (1816)
25 UAC.ti,ab. (435)
26 (umbilical adj3 cathet$).ti,ab. (1708)
27 (umbilical adj3 cannul$).ti,ab. (89)
28 (umbilical adj3 line$).ti,ab. (422)
29 Broviac.ti,ab. (395)
30 Hickman.ti,ab. (1038)
31 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 (106884)
32 12 and 31 (8504)
33 clinical trial/ (920773)
34 randomized controlled trial/ (445616)
35 randomization/ (73342)
36 single blind procedure/ (26575)
37 double blind procedure/ (137474)
38 crossover procedure/ (50870)
39 placebo/ (304347)
40 randomi?ed controlled trial$.tw. (155509)
41 rct.tw. (23732)
42 random allocation.tw. (1668)
43 randomly allocated.tw. (27182)
44 allocated randomly.tw. (2236)
45 (allocated adj2 random).tw. (861)
46 single blind$.tw. (19159)
47 double blind$.tw. (177157)
48 ((treble or triple) adj blind$).tw. (684)
49 placebo$.tw. (252743)
50 prospective study/ (370954)
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51 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 (1733765)
52 case study/ (46451)
53 case report.tw. (335270)
54 abstract report/ or letter/ (1012042)
55 52 or 53 or 54 (1386028)
56 51 not 55 (1688954)
57 32 and 56 (857)
******************************************************
Database:Maternity & Infant Care Database (MIDIRS) via OVID <1971 to March 2017>
Search date = 11 May 2017
--------------------------------------------------------------------------------
1 (neonat$ or neo nat$).ti,ab. (37541)
2 (newborn$ or new born$ or newly born$).ti,ab. (17281)
3 (preterm or preterms or pre term or pre terms).ti,ab. (21945)
4 (preemie$ or premie or premies).ti,ab. (48)
5 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (3526)
6 (low adj3 (birthweight$ or birth weight$)).ti,ab. (9603)
7 (lbw or vlbw or elbw).ti,ab. (2624)
8 infan$.ti,ab. (55675)
9 (baby or babies).ti,ab. (26173)
10 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 (103259)
11 Catheterization.de. (1)
12 Catheters.de. (2)
13 catheter$.ti,ab. (1659)
14 (central adj3 line$).ti,ab. (150)
15 catheter$.ti,ab. (1659)
16 peripherally-inserted.ti,ab. (82)
17 CVC.ti,ab. (36)
18 CVL.ti,ab. (5)
19 PCVC.ti,ab. (10)
20 PICC.ti,ab. (46)
21 Umbilical veins.de. (65)
22 UVC.ti,ab. (24)
23 UAC.ti,ab. (19)
24 (umbilical adj3 cathet$).ti,ab. (186)
25 (umbilical adj3 cannul$).ti,ab. (2)
26 (umbilical adj3 line$).ti,ab. (25)
27 Broviac.ti,ab. (2)
28 Hickman.ti,ab. (3)
29 11 or 12 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 (1823)
30 10 and 29 (1049)
31 limit 30 to randomised controlled trial (53)
******************************************************
Database:CENTRAL via John Wiley’s Cochrane Library Interface
Search Name: central lines Infants 11052017
Records retrieved = 372
IDSearch
#1 MeSH descriptor: [Infant, Newborn] explode all trees
#2 MeSH descriptor: [Premature Birth] explode all trees
#3 neonat*:ti,ab,kw (Word variations have been searched)
#4 neo-nat*:ti,ab,kw (Word variations have been searched)
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#5 newborn or new born* or newly born*:ti,ab,kw (Word variations have been searched)
#6 preterm or preterms or (pre term) or (pre terms):ti,ab,kw (Word variations have been searched)
#7 preemie* or premie or premies:ti,ab,kw (Word variations have been searched)
#8 prematur* near/3 (birth* or born or deliver*):ti,ab,kw (Word variations have been searched)
#9 low near/3 (birthweight* or birth weight*):ti,ab,kw (Word variations have been searched)
#10 lbw or vlbw or elbw:ti,ab,kw (Word variations have been searched)
#11 infan* or baby or babies:ti,ab,kw (Word variations have been searched)
#12 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11
#13 MeSH descriptor: [Catheterization, Central Venous] explode all trees
#14 MeSH descriptor: [Catheters] explode all trees
#15 MeSH descriptor: [Catheters, Indwelling] explode all trees
#16 MeSH descriptor: [Central Venous Catheters] explode all trees
#17 central near/3 line*:ti,ab,kw (Word variations have been searched)
#18 peripherally-inserted:ti,ab,kw (Word variations have been searched)
#19 CVC or CVL or PCVC or PICC:ti,ab,kw (Word variations have been searched)
#20 MeSH descriptor: [Umbilical Veins] explode all trees
#21 UVC or UAC:ti,ab,kw (Word variations have been searched)
#22 (umbilical near/3 (cathet* or cannul* or line*)):ti,ab,kw (Word variations have been searched)
#23 Broviac or hickman:ti,ab,kw (Word variations have been searched)
#24 #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23
#25 #12 and #24
******************************************************
Trials registers searches
ClinicalTrials.gov
https://clinicaltrials.gov/ct2/home
11 May 2017
147 studies found for: catheter AND infant
WHO ICTRP
http://apps.who.int/trialsearch/Default.aspx
11 May 2017
((central line*) OR catheter*) AND infant* 10 records
Appendix 2. Risk of bias
• Random sequence generation: We categorised the method used to generate the allocation sequence as:
◦ Low risk of bias: any random process (e.g. random number table; computer random number generator; coin tossing;
shufﬂing of cards or envelopes; throwing of dice; drawing of lots; minimization) implemented without a random element (this is
considered equivalent to being random);
◦ High risk of bias: any non-random process (e.g. sequence generated by odd or even date of birth; date (or day) of admission;
sequence generated by hospital or clinic record number; allocation by judgement of the clinician; allocation by preference of the
participant; allocation based on results of a laboratory test or series of tests; allocation based on availability of the intervention); or
◦ Unclear risk of bias: insufﬁcient information about the sequence generation process to permit judgement.
• Allocation concealment: We categorised the method used to conceal the allocation sequence as:
◦ Low risk of bias: randomisation method described that would not allow investigator/participant to know or inﬂuence the
intervention group before eligible participants entered the study (i.e. central allocation, including telephone, Web-based, and
pharmacy-controlled randomisation; sequentially numbered drug containers of identical appearance; sequentially numbered opaque,
sealed envelopes);
◦ High risk of bias: open random allocation schedule (i.e. list of random numbers); assignment envelopes used without
appropriate safeguards (e.g. envelopes were unsealed or non-opaque, were not sequentially numbered); alternation or rotation; date of
birth; case record number; any other explicitly unconcealed procedure; or
◦ Unclear risk of bias: randomisation stated but no information provided on method used.
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• Blinding of participants and personnel: We assessed blinding of participants, clinicians and caregivers, and outcome assessors
separately for different outcomes and categorised methods as:
◦ Low risk of bias: no blinding or incomplete blinding, but review authors judged that the outcome was not likely to be
inﬂuenced by lack of blinding; blinding of participants and key study personnel ensured, and unlikely that blinding could have been
broken;
◦ High risk of bias: no blinding or incomplete blinding, and outcome was likely to be inﬂuenced by lack of blinding;
blinding of key study participants and personnel attempted, but likely that blinding could have been broken, and the outcome was
likely to be inﬂuenced by lack of blinding; or
◦ Unclear risk of bias: insufﬁcient information to permit judgement.
• Incomplete outcome data: We described completeness of data including attrition and exclusions from the analysis for each
outcome and reasons for attrition or exclusion when reported. We assessed whether missing data were balanced across groups or were
related to outcomes. We categorised completeness as:
◦ Low risk of bias: no missing outcome data; reasons for missing outcome data unlikely to be related to true outcome (for
survival data, censoring unlikely to introduce bias); missing outcome data balanced in numbers across intervention groups, with
similar reasons for missing data across groups; for dichotomous outcome data, proportion of missing outcomes compared with
observed event risk not enough to have a clinically relevant impact on the intervention effect estimate; for continuous outcome data,
plausible effect size (difference in means or standardised difference in means) among missing outcomes not sufﬁcient to have a
clinically relevant impact on observed effect size; missing data imputed by appropriate methods;
◦ High risk of bias: reason for missing outcome data likely to be related to true outcome, with imbalance in numbers or
reasons for missing data across intervention groups; for dichotomous outcome data, proportion of missing outcomes compared with
observed event risk enough to induce clinically relevant bias in intervention effect estimate; for continuous outcome data, plausible
effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias
in observed effect; ’as-treated’ analysis done with substantial departure of the intervention received from that assigned at
randomisation; potentially inappropriate application of simple imputation; or
◦ Unclear risk of bias: insufﬁcient information to permit judgement.
Appendix 3. GRADE
GRADE considers that evidence from randomised controlled trials is of “high” quality, but that assessment may be downgraded based
on consideration of any of ﬁve areas.
• Design (risk of bias) (Guyatt 2011b).
• Consistency across studies (Guyatt 2011c).
• Precision of estimates (Guyatt 2011d).
• Directness of evidence (Guyatt 2011e).
• Presence of publication bias.
This results in assessment of the quality of a body of evidence as one of four grades.
1. High: We are very conﬁdent that the true effect lies close to that of the estimate of the effect.
2. Moderate: We are moderately conﬁdent in the effect estimate: The true effect is likely to be close to the estimate of the effect,
but there is a possibility that it is substantially different.
3. Low: Our conﬁdence in the effect estimate is limited: The true effect may be substantially different from the estimate of the
effect.
4. Very low: We have very little conﬁdence in the effect estimate: The true effect is likely to be substantially different from the
estimate of effect.
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